Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SIBN · against 459 other Healthcare companies of similar size
Ranked #338 of 460 · scores higher than 25% of peers
Bars: peers in each 10-point band of the profitability score44 peers with a profitability score of 20–29, including SIBN · Click a bar to see the companies
Mainly because of its return on invested capital, operating margin and return on assets, which are weaker than most Healthcare peers.
| Metric | SIBN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 436 reported | -18.2% | 4.5% | 20% | 33% | |
| Operating marginHigher is better · 429 reported | -11.1% | 6.9% | 22% | 33% | |
| Return on assetsHigher is better · 447 reported | -4.6% | 1.5% | 28% | 33% | |
| Return on equityHigher is better · 430 reported | -8.3% | 2.8% | 32% | Context only | |
| Gross marginHigher is better · 479 reported | 79.5% | 47.8% | 88% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 3 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 3 | 595M USD | 99 | 97 | |
| 3 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 338 | 15.4B HKD (≈$2.0B) | 28 | 44 | |
| 338 | 4.7B CNY (≈$661M) | 28 | 26 | |
| 338 | 5.9B HKD (≈$760M) | 28 | 59 | |
| 338 | 1.2B USD | 28 | 36 | |
| 338 | 1.1B USD | 28 | 50 | |
| 338 | 1.6B USD | 28 | 48 | |
| 344 | 143.9B JPY (≈$978M) | 27 | 26 | |
| 344 | 7.4B CNY (≈$1.0B) | 27 | 34 | |
| 344 | 1.6B USD | 27 | 33 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score